Case File №
#VI-2026-0413
Amino Lair
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | B Good | 6 | 7.4 | 5.7 | 9.7 | 11 Aug 2025 |
| Retatrutide | D Poor | 6 | 6.2 | 4.0 | 8.0 | 21 Aug 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 5.2 | 5.2 | 5.2 | 20 Jun 2025 |
| AA Water | X N/A | 1 | 4.0 | 2.9 | 2.9 | 3 Jul 2025 |
| ACE-031 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 17 Dec 2024 |
| Adipotide | X N/A | 1 | 5.9 | 5.9 | 5.9 | 28 Mar 2025 |
| AICAR | X N/A | 1 | 6.6 | 6.6 | 6.6 | 13 Feb 2025 |
| APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 8 Jul 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 9.2 | 9.2 | 9.2 | 16 Mar 2025 |
| Boldenone Cypionate | X N/A | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 |
| Botulinum toxin | X N/A | 1 | 5.2 | 5.2 | 5.2 | 27 Feb 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 5.9 | 5.9 | 5.9 | 2 Apr 2025 |
| Cerebrolysin | X N/A | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 7.8 | 7.8 | 7.8 | 20 Jun 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 6.0 | 6.0 | 6.0 | 9 Jun 2025 |
| Clomid | X N/A | 1 | 5.4 | 5.4 | 5.4 | 8 Jul 2025 |
| Deca (Nandrolone Decanoate) | X N/A | 1 | 5.9 | 5.9 | 5.9 | 16 Mar 2025 |
| Dutasteride | X N/A | 1 | 7.2 | 7.2 | 7.2 | 14 Jan 2025 |
| Epithalon | X N/A | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 |
| EPO | X N/A | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 |
| Glutathione | X N/A | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 |
| HCG | X N/A | 1 | 8.2 | 8.2 | 8.2 | 28 Mar 2025 |
| IGF-1 LR3 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
| Lipo-C 120mg | X N/A | 1 | 9.0 | 9.0 | 9.0 | 25 Apr 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 |
| NA Selank Amidate | X N/A | 1 | 8.5 | 8.5 | 8.5 | 2 Apr 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 6.5 | 6.5 | 6.5 | 17 Dec 2024 |
| Oxytocin Acetate | X N/A | 1 | 9.0 | 9.0 | 9.0 | 3 Jul 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 27 Feb 2025 |
| Romosozumab | X N/A | 1 | 7.0 | 7.0 | 7.0 | 20 Jun 2025 |
| SNAP-8 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 |
| Tadalafil (Cialis) | X N/A | 1 | 4.9 | 4.9 | 4.9 | 27 Feb 2025 |
| Testagen | X N/A | 1 | 9.3 | 9.3 | 9.3 | 20 Jun 2025 |
| TrenMix 200 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 |
| Trestolone Acetate (MENT) Raw | X N/A | 1 | 7.8 | 7.8 | 7.8 | 3 Jun 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 6.5 | 6.5 | 6.5 | 7 May 2025 |
| Winstrol Oil | X N/A | 1 | 5.7 | 5.7 | 5.7 | 21 May 2025 |
Exhibit II
Evidence Log
42 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | EPO | 6.1 A | 10mg | 9.9mg | -1.1% | 98.87% | mmxsjn | Lab C | Public |
| 25 May 2026 | Lipo-C 120mg | 8.6 A | 200mg/ml | 223.6mg/ml | +11.8% | 95.56% | msqq9m | Lab G | Community |
| 24 May 2026 | Adipotide | 5.5 B | 15mg | 17.2mg | +14.4% | 95.94% | 5qf5p0 | Lab C | Public |
| 24 May 2026 | Aromasin (Exemestane) | 8.8 A | 20mg | 17.1mg | -14.5% | 98.00% | my9r5d | Lab A | Community |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.2 A | 30mg | 30.9mg | +3.1% | 98.88% | xl8t0e | Lab C | Public |
| 24 May 2026 | Romosozumab | 7.3 A | 20mg | 18.4mg | -7.9% | 96.32% | u7hj7o | Lab G | Public |
| 24 May 2026 | Tadalafil (Cialis) | 4.2 C | 10mg | 9.3mg | -7.3% | 99.98% | khc1ll | Lab G | Community |
| 23 May 2026 | HCG | 7.7 A | 20mg | 24.9mg | +24.7% | 97.49% | f5k2f1 | Lab C | Community |
| 23 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.8 A | 1g | 0.9g | -5.2% | 96.77% | ltcs0p | Lab E | Community |
| 23 May 2026 | Glutathione | 5.8 B | 10mg | 11.8mg | +17.8% | 96.90% | f6gily | Lab B | Public |
| 21 May 2026 | Deca (Nandrolone Decanoate) | 4.3 C | 250mg/ml | 255.2mg/ml | +2.1% | 98.93% | 5glrii | Lab C | Community |
| 21 May 2026 | SNAP-8 | 6.5 A | 2mg | 2.0mg | +1.8% | 95.26% | lehyn0 | Lab F | Community |
| 21 May 2026 | Oxytocin Acetate | 7.6 A | 50mg | 57.8mg | +15.7% | 96.56% | 3sgsve | Lab F | Public |
| 20 May 2026 | Dutasteride | 8.8 A | 100mg | 118.5mg | +18.5% | 95.86% | exrvll | Lab C | Public |
| 19 May 2026 | Masteron P (Drostanolone P) | 4.3 C | 100mg/ml | 102.3mg/ml | +2.3% | 97.96% | 4tek3n | Lab D | Public |
| 19 May 2026 | Vitamin B12 10mg/ml | 5.8 B | 100mg/ml | 93.1mg/ml | -6.9% | 96.75% | c89htb | Lab B | Public |
| 17 May 2026 | TrenMix 200 | 6.0 A | 250mg/ml | 302.7mg/ml | +21.1% | 96.39% | e0s3sq | Lab E | Public |
| 17 May 2026 | Trestolone Acetate (MENT) Raw | 8.5 A | 10g | 11.7g | +17.0% | 98.55% | 5m4wa8 | Lab F | Community |
| 29 Jan 2026 | ACE-031 | 8.1 A | 30mg | 34.9mg | +16.3% | 98.21% | oguwmp | Lab B | Community |
| 29 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 4.7 C | 10mg | 8.9mg | -11.5% | 99.32% | 3rs33c | Lab G | Public |
| 26 Jan 2026 | AA Water | 5.3 B | 30mg | 35.4mg | +18.0% | 95.98% | qrbcnh | Lab F | Public |
| 26 Jan 2026 | Boldenone Cypionate | 6.1 A | 250mg/ml | 297.0mg/ml | +18.8% | 95.47% | x85ks3 | Lab A | Public |
| 26 Jan 2026 | Botulinum toxin | 6.3 A | 2mg | 2.2mg | +11.9% | 97.08% | ujia4s | Lab A | Community |
| 26 Jan 2026 | IGF-1 LR3 | 8.6 A | 5mg | 5.0mg | +0.9% | 95.96% | sd2c95 | Lab A | Public |
| 26 Jan 2026 | NA Selank Amidate | 7.5 A | 30mg | 30.6mg | +2.0% | 98.63% | 2wjuyr | Lab C | Community |
| 19 Jan 2026 | Clomid | 5.6 B | 50mg | 54.5mg | +9.0% | 96.09% | dv0t3r | Lab C | Public |
| 9 Jan 2026 | Winstrol Oil | 7.5 A | 300mg/ml | 371.0mg/ml | +23.7% | 95.37% | b8los9 | Lab E | Community |
| 7 Jan 2026 | Tirzepatide | 6.0 B | 20mg | 22.4mg | +12.0% | 99.90% | (no batch ID) | Lab G | Public |
| 6 Jan 2026 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 5.8 B | 10g | 8.9g | -10.7% | 97.10% | pm003f | Lab B | Community |
| 10 Dec 2025 | Retatrutide | 5.8 C | 10mg | 10.9mg | +9.0% | 99.50% | (no batch ID) | Lab G | Public |
| 5 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 8.5 A | 10mg | 11.6mg | +15.6% | 96.59% | lx0sj8 | Lab F | Public |
| 23 Nov 2025 | AICAR | 4.0 C | 15mg | 13.5mg | -10.2% | 99.61% | g5kplc | Lab G | Public |
| 17 Nov 2025 | Cerebrolysin | 7.1 A | 10mg | 11.1mg | +11.0% | 98.62% | co8emr | Lab F | Community |
| 5 Nov 2025 | Epithalon | 5.4 B | 20mg | 21.1mg | +5.5% | 97.84% | cy0ufn | Lab E | Public |
| 4 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.2 B | 10mg | 9.6mg | -4.5% | 99.73% | aut7xj | Lab D | Public |
| 17 Oct 2025 | 4-Anilinopiperidine CAS 99918-43-1 | 4.5 C | 500g | 569.8g | +14.0% | 97.22% | ylbr3g | Lab B | Public |
| 17 Oct 2025 | Testagen | 7.3 A | 50mg | 59.9mg | +19.8% | 98.06% | vhy3gz | Lab C | Community |
| 14 Oct 2025 | Retatrutide | 4.2 D | 10mg | 12.2mg | +22.0% | 99.60% | (no batch ID) | Lab G | Public |
| 9 Oct 2025 | Retatrutide | 7.3 A | 30mg | 30.3mg | +1.0% | 99.60% | (no batch ID) | Lab E | Public |
| 6 Oct 2025 | Retatrutide | 4.0 D | 10mg | 12.4mg | +24.0% | 99.50% | (no batch ID) | Lab G | Public |
| 3 Oct 2025 | Tirzepatide | 7.7 A | 10mg | 10.1mg | +1.0% | 99.79% | (no batch ID) | Lab E | Public |
| 30 Sep 2025 | Retatrutide | 8.0 A | 30mg | 28.6mg | -4.7% | 99.92% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —